Cadrenal Therapeutics, Inc.
NASDAQCVKD short interest surges 46% in one week to 3.24% of float, driven by clinical progress ahead of earnings call tomorrow.
Snapshot as of 2 Jul 2026
No long-form analysis yet for CVKD. Pulse alerts and the live data picture are available on ORTEX.
Open CVKD on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CVKD — free to start on ORTEX.
Sign up for free →Open CVKD on ORTEX